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A general synthetic method to conjugate cysteine-containing peptides to nucleosides via a disulfide
link has been developed, using the heterobifunctional reagent N-succinimidyl-3-(2-pyridyl-
thio)propionate(SPDP) and amino-modified nucleosides. Representative compounds based on C-6
modified adenosine, C-5 modified uridine and 2'-deoxyuridine are reported, along with extensive NMR
characterizations of these novel nucleosides. .
The class of bioconjugates known as nucleoside
peptides is of considerable interest because of their
established biological activity. These bioconjugates
occur naturally in.the genomes of certain RNA and
DNA viruses, where they play an important role in
viral replication. Generally, the proteins are linked
to a 5'-phosphate of a nucleic acid moiety via a
phosphodiester bond to serine, tyrosine or
threonine'. Another naturally occurring example of
RNA-amino acid bioconjugates is the family of
aminoacyl-tRNA molecules in which the amino
acid is esterified to the 2'- or 3'-hydroxyl group at
the ·3'-end of the tRNA chain", Synthetic DNA-
enzyme conjugates have been used as sequence-
specific, oligonucleotide-directed nucleases':",
Oligonucleotides have been conjugated to peptides
such as cationic polylysine" and hydrophobic
polytryptophan to enhance cellular uptake. The
sequence-specific inhibitory effect of poly-l.-Iysine
antisense conjugates has been demonstratedi'".
Conjugation of oligoarginine peptides or ornithine
peptides to oligonucleotides was reported to
promote membrane penetration of these
bioconjugates and increase their binding affinities
to their complementary DNA strands 10·12
Recently, molecules such, as cholesterol and
cyclodextrin have been conjugated to synthetic
oligonucleotides to enhance their antisense activity,
and higher antisense activity has been related to
their increased cellular uptake'<'". Reversible
nucleosides are designed to link cell binding
proteins to nucleic acids via disulfide groups.
Uptake of these nucleic acid-protein bioconjugates
will be enhanced by cell binding protein but free
nucleic acid will be released into the cell.Because
of the growing importance of nucleic acid-protein
conjugates, we have undertaken the preparation
and characterization of a series of oligonucleotide-
peptide bioconjugates in order to mimic naturally
occurring systems, and because oligonucleotides
with pendant peptides may have advantageous
reactivity or drug delivery properties. We have
earlier reported the synthesis and characterization
of nucleoside-histidine conjugates and oligonucleo-
tide-histidine and lysine derivatives'<", We report
herein the preparation and characterization of 3-
nucleoside cysteine conjugates.
Results and Discussion
As shown in Scheme I,' we chose C-5
substituted 2'-deoxyuridine as our parent synthetic
substrate. C-5 modified nucleoside derivatives can
be incorporated into oligonucleotides without
disrupting with Watson-Crick base pairing to
complementary strands. Nucleoside 1was prepared
by the literature method 18. It was coupled with
SPDP to give nucleoside 2 with a purified yield of
68%. Fully assigned \3C and IH NMR data are
given in the Experimental Section. The quaternary
carbon C13, as shown in Scheme I, was identified
as the resonance at 159.7 ppm from the ID \3C
APT spectrum of 2. The other \3C assignments of
the thiopyridine moiety of the SPDP nucleoside
conjugate were initially ambiguous, and because of
the many overlapping proton resonances in the
aromatic region, heteronuclear correlation





techniques would not have been effective in
completing the identification. Therefore, to analyze
the J3C spectrum, the INADEQUATE experiment"
was employed to obtain 2D J3C_I3C connectivity
information of a model compound, pyridine-2-
thiol. The assignment of the remaining carbons in
the pyridine ring was made by their connectivity
with the previously identified quaternary carbon
resonance. This spectral analysis was used to help
assign the I3C spectra of compounds 7 and 9,
described below. The disulfide 2, which can be
Scheme I
regarded as a protected thiol, withstood
detritylation conditions, as indicated by the 92%
yield for the conversion of 2 to 3. When 2 was
treated with one equiv. of N-acetyl-L-cysteine, the
resulting bioconjugate 4 was isolated in 85%
overall yield after deprotection of both the 5'-0-
trityl and N-acetyl groups and chromatographic
purification.
We extended the deoxyuridine methodology of
Scheme I to the synthesis of the ribonucleoside
analogues, shown in Scheme n. Ribonucleoside 5
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was prepared by treating a known C-5 substituted
uridine derivative'" with ethylenediamine. This
ribonucleoside was then treated with a 3-fold
excess of SPDP in DMF. The intermediate product
6 was not isolated but was acetylated with acetic
anhydride to improve its solubility and lipophilicity
for easier isolation, giving 7 in 82% overall yield.
The disulfide moiety was stable to the acetylation
conditions.
A further example of ribonucleoside-cysteine
conjugates is given in Scheme III. Compound 8,
which proved to be a useful substrate, was derived
from the alkylation of a large excess of
ethylenediamine with 6-chloropurine ribonucle-
oside'" in 90% yield. On treatment of8 with SPDP,
7(S2%)
Scheme n
the disulfide 9 was obtained in 70% yield, and a
disulfide exchange reaction with L-cysteine
hydrochloride hydrate gave the nucleoside lOin
80% yield.
Conclusions
We have developed a methodology for the
introduction of disulfide group into ribonucleosides
and 2'-deoxyribonucleosides, and we have
demonstrated how this procedure can be used to
prepare nucleoside-peptide bioconjugates derived
from cysteine. No unwanted modifications of the
nucleic acid bases occur in the course of this
chemistry, as indicated by the extensive
characterization of the products, including high
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resolution mass spectral data and 'H and I3C NMR
data.
Experimental Section
General. NMR spectra were recorded on Varian
UNITY plus-500, UNITY-600, and VXR-400
spectrometers. Exchangable protons are labeled
(ex.). The high resolution mass spectra were
recorded on a Finnegan/MAT90 spectrometer. The
FAB+ low resolution spectra were run on a VG 40-
250T spectrometer where the FAB matrix was a
saturated solution of LiI in 3-nitrobenzyl alcohol,
which is especially useful for acid-labile, protected
nucleosides. Thin layer chromatography was
performed on Baker-Flex Silica gel IB2-F plates.
10(80%)
Scheme [[I
Flash column chromatography was performed on
silica gel (Merck SG-60, 230-240 mesh). Reverse
phase (RP) column chromatography was carried
out using an Alltech Econosil C-18 silica gel. RP
HPLC was carried out on an Alltech Econosil C-18
preparative column (10 u, 22.5 x 250 mm) using a
linear ternary gradient flowing at 6 mLimin.
Solvent A (O.lM [Et3NH]OAc) was kept constant
at 25%, while B (MeCN) and C (H20) were varied
as follows, where time is in min: (time, %B, %C),
(0, 5, 70), (3, 5, 70), (33, 35,40), (45, 70, 5). The
HPLC was monitored simultaneously at 260 and
400 nm. SPDP (Pharmacia), N-acetyl-L-cysteine
(Sigma), and L-cysteine hydrochloride hydrate
(Sigma) were used as received.
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5-[3- [[[[2-[2-Pyridyldithio]ethyl]amino]ethyl]-
amino]- 3-oxopropyl]-5'-O-DMT -2'-deoxyuri-
dine 2. A solution of nucleoside" (0.322 g, 0.5
mmol) in DMF (5 mL) and Et3N(0.2 mL) was
cooled to OoC in an ice-bath and SPDP (0.469 g,
1.5 mmoles) was added to the stirred reaction
mixture. After 15 min the ice bath was removed
and the mixture was stirred at room temperature for
24 hr. The reaction mixture was diluted with 20 mL
CH2Ch and washed with water (10 mL). The
organic layer was dried, concentrated and
chromatographed on silica (6% EtOWCH2Ch) to
give the desired product 2 (0.285 g, 68%). Rr
0.4(10% EtOHlCH2Ch). \3C NMR (75 MHz,
CDCh) : 84.9 (C1'), 40.8 (C2')," 72.2 (C3'), 86.2
(C4'), 63.9 (C5'), 164.2 (4CO), 150.7 (2CO), ll3.7
(C5), l37.2 (C6), 23.6 (C7), 35.4 (C8), 39.8 & 39.2
(C9 & C10), 35.5 (Cll), 34.2 (C12), 159.7 (Cl3),
l37.4 (C15), 120.2 (C14), 121.1 (C16), 149.5
(C17), 55.3 [OCH3(DMT)], 86.8 [C(Ph)(phOMe)2],
173.0 (C18), 171.7 (C19); IH NMR (300 MHz,
CDCb): 86.35 (t, lH, HI'), 2.2 & 2.4 (m, 2H,
H2'), 4.5 (m, lH, H3'), 4.05 (m, IH, H4'), 3.4 (m,
2H, H5'), 7.55 (s, lH, H6), 2.1 & 2.2 (m, 4H, H7 &
H8), 3.25 (m, 4H, H9 & HlO), 2.55 (t, 2H, Hll),
2.95 (t, 2H, H12), 7.65 (t, lH, H14), 7.60(d, ur,
H15), 7.05 (m, 1H, H16), 8.35 (d, lH, H17), 3.75
(s, 6H, OCH3(DMT». FAB HRMS m/z)
C43H47Ns09S2Lt: Ca1cd 848.2975, Found
848.2841; MS (FAB) : m/z 854 [M+2Li-H],




solution of2 (0.42 g, 0.5mmole) in CH2Ch (5 mL)
was treated with 0.01 N HCI, pH 2 (5 mL) for 0.5
h. The mixture was washed with CH2Ch (2 x 20
mL), then lyophilized twice to yield the final
product 3 (0.220 g, 92%). \3C NMR (75 MHz,
CD30D) : 86.3 (Cl'), 41.2 (C2'), 72.2 (C3'), 88.9
(C4'),62.9 (C5'), 165.7 (4CO), 152.2, (2CO), 114.1
(C5), l39.1 (C6), 24.2 (C7), 35.8 (C8), 40.0 &
39.9, (C9 & ClO), 36.1 (Cll), 35.3 (C12), 161.2
(Cl3), 121.2 (C14), l39.1 (C15), 122.4 (C16),
150.4 (Cl7), 175.2 (C18), 173.6 (C19); IH NMR
(300 MHz, D20) :8 6.2 (t, 1H, HI'), 2.3 (m, 2H,
H2'), 4.4 (m, 1H, H3'), 3.95. (m, lH, H4'), 3.75 (m,
2H, H5'), 7.6 (s, 1H, H6), 2.5 (2 t's, 4H, H7 & H8),
3.3 (s, 4H, H9 & HlO), 2.6 (t, 2H, H1l), 3.05 (t,
2H, H12), 8.2 (d, 1H, H14), 8.4 (t, lH, HIS), 7.8 (t,
lH, H16), 8.6 (d, lH, H17). FAB HRMS m/z
C22H29Ns07S2Lt: Calcd 546.5647, Found
546.5673; MS (FAB) : m/z 546 [M+Li], 435
[M+Li-CsHsNS], 430 [M+Li+H-sugar].
5- [3-[ [[[2- [L-Cystamide]thioethyl] amino ]ethyl]-
amino]-3-oxopropyl]-2'-deoxyuridine 4. To a
solution of 2 (0.084 g, 1.0 mmole) in CH2Ch (0.5
mL) was added a solution of N-acetyl-
cysteine(0.17 g, 1.0 mmole) in CH3CN(0.25 mL).
The mixture was stirred at room temperature for 30
min and concentrated to dryness. The residue was
chromatographed on silica (8-12% EtOHlCH2Ch).
The crude product was treated with conc.aq. NH3(5
mL) for 24 hr and concentrated to dryness, then
treated with 0.01 M HCl (PH 2) for 0.5 b and
washed with CH2Ch (2 x 5 mL), and purified by
RP HPLC (retn. time 25 min) to yield 4 (0.046 g,
85%). \3C NMR (75 MHz, D20) : 88.1 (C1'), 43.1
(C2'), 73.4 (C3'), 89.5 (C4'), 64.2 (C5'), 168.4
(4CO), 154.4 (2CO), 116.3 (C5), 141.2 (C6), 24.9
(C7), 37.4 (C8), 41.7 and 41.6 (C9 & C10), 37.8
(C1l), 36.3 (C12), 25.8 (Cl3), 56.8 (C14), 178.3
(C15), 177.3 (C16), 176.7 (C17); IH NMR (300
MHz, D20) : 86.30 (t, lH, HI', J=6.6 Hz), 2.35 (m,
2H, H2'), 4.45 (m, 1H, H3'), 4.05 (m, lH, H4'),
3.80 (m, 2H, H5'), 7.70 (s, lH, H6), 2.55 (2 t's, 4H,
H7 & H8), 3.31 (s, 4H, H9 & HlO), 2.65 (t,2H,
Hll, J=6.6 Hz), 2.80 (t, 2H, H12), 3.10 (m, Hl3,
2H), 4.55 (m, H14, lH). FAB HRMS m/z
C2oH32N60SS2Lt: Ca1cd 555.5724; Found
555.5745; MS (FAB) : m/z 555 [M+Li], 549
[M+H], 439 [M+Li+H-sugar].
5-[3- [2-Aminoethyl)amino ]-3-oxopropyl]uridine
5. 5-(2-Carbomethoxyethyl) uridine'" (3.96 g, 12
mmoles) was stirred with ethylenediamine (7.2
mL) for 60 hr. The reaction mixture was
concentrated to dryness, chromatographed on silica
(1-3% NH3IEtOH) to give pure product 5 (3.8 g,
90%). \3C NMR (75 MHz, MeOD) : 90.7 (Cl'),
75.7 (C2'), 71.4 (C3'), 86.4 (C4'), 62.5 (C5'), 167.8
(4CO), 154.2 (2CO), 114.4 (C5), l38.8 (C6), 24.5
(C7), 35.9 (C8), 42.0 & 44.4 (C9 & C10), 175.4,
(Cll); IH NMR (300 MHz, D20) : 8 5.93 (d,
IH,Hl'), 4.25 (m, 1H, H2'), 4.21 (m, nr, H3'), 4.05
(m, 1H, H4'), 3.85 (m, 2H, H5'), 7.50 (s, 1H, H6),
2.52 (2 t's, 4H, H7 & H8), 3.01 (m , 4H, H9 &
HI0). FAB HRMS m/z CI4H22N401Lt:Ca1cd
365.2930; Found 365.2967; MS (FAB) : m/z 365
[M+Li], 359 [M+H].
5-[3-[[ [[2-[2- Pyridyldithio] ethyl] amino ]-
ethyl]amino]-3-oxopropyl]-2', 3', 5'-tri-O-
acetyluridine 7. Nucleoside 5 (0.178 g, 0.5
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mmole) and Et3N (0.2 mL) in DMF (5 mL) were
cooled in an ice-bath. SPDP (0.469 g, 1.5 mmoles)
was added. The reaction mixture was stirred for
lSmin, then the ice-bath was removed. The mixture
was stirred at room temperature for another 24hr.
Acetic anhydride (0.306 g, 3 mmoles).in CH2Ch (5
mL) was added to the reaction mixture and left
stirring for 2 hr. After quenching with water (2
mL), the mixture was extracted with CH2Ch (3 x
10 mL). The organic layer was dried and
concentrated to give the crude product. The residue
was purified by chromatography on silica (3 %
EtOHlCH2Ch) to give the product 7 (0.279 g,
82%). RtO.48 (5% EtOHlCH2Ch). 13cNMR (75
MHz, CDCh) ppm 87.8 (Cl'), 72.7 (C2'), 70.3
(C3'), 79.8 (C4'), 63.2 (C5'), 163.6 (4CO), 150.3
(2CO), 113.9 (C5), 137.3 (C6), 23.1 (C7), 34.8
(C8), 39.5 & 39.6 (C9 & Cl.O), 35.5 (Cll), 34.3
(C12), 159.6 (C13), 137.5 (C15), 120.2 (CI4),
121.0 (C16), 149.5 (C17), 172.7 (C20), 171.7
(C21), 169.7, 169.8, 170.6, 19C; 20.5, 20.9, 20.7
18C; 'H NMR (300 MHz, CDCh) : 86.10 (d, IH,
HI'), 5.3~ (m, IH, H2'), 4.35 (m, IH, H3'), 4.35
(m, IH, H4'), 4.30 (m, 2H, H5'), 7.35 (s, IH, H6),
2.51 (2 t's, 4H, H7 & H8), 3.35 (m, 4H, H9 &
HIO), 2.60 (t, 2H, Hll), 3.01 (t, 2H, H12), 7.65 (m,
IH, H14), 7.65(m, IH, HI5), 7.12 (m, 1H, H16),
8.40 (m, 1H, H17), 6.85, 7.15, 9.95 (br, 3H, NH);
2.00 & 2.21 (3 s's, 9H, COCH3). FAB HRMS m/z
C28H3SNsOIlS2Li+: Calcd 688.6770, Found
688.6783; MS (FAB) : m/z 682 [M + H], 609
[M+Li-CsHsNS], 577[M+Li-CsHsNS], 430
[M+Li+H-sugar].
N-[2-[[[2- [2-Pyridyldithiol ethyl] carbonyl]-
amino] ethyl] adenosine 9. To a solution of N-
amino ethyl adenosine" 8 (0.310 g, 1 mmole) in
DMSO (3.0 mL) was added SPDP (0.313 g, 1
mmole). The reaction mixture was stirred at room
temperature for 24 hr under N2, and concentrated to
dryness. Ethyl acetate (10 mL) and MeOH(2 mL)
were added to the resulting thick syrup, and the
mixture was vigorously mixed with a spatula until
a white solid separated, and stored at ODC for 2hr.
The final product 9 was obtained as a white solid
(355 mg, 70%). m.p, 160 DC (d); IR (Nujol) : 3301,
1733, 1632, 1540, 1377 ern"]. I3C NMR (125
MHz, DMSO-d6) : 88.1 (Cl'), 73.7 (C2'), 70.8
(C3'), 86.1 (C4'), 61.8 (C5'), 152.4 (C2), 148.5
(C4), 154.8 (C5), 119.3 (C6), 139.9 (C8), 39.2
(C9), 38.6 (C10), 34.5 (C11), 33.7 (C12), 159.0
(C13), 119.3 (C14), 137.9 (C15), 121.3 (C16),
149.7 (CI7), 169.9 (C18); 'H NMR (500 MHz,
DMSO-d6) : 8 5.84 (d, IH, HI'), 4.57 (m, 1H, H2'),
4.11 (m, IH, H3'), 3.92 (m, IH, H4'), 3.63 and 3.50
(dd, 2H, H5'), 8.17 (s, IH, H2), 8.32-'(s, IH, H8),
3.50 (m, 2H, H9), 3.26 (t, 2H, HIO), 2.43 (t, 2H,
IlH), 2.94 (m, 2H, 12H), 7.71 (d, 2H, HI4), 7.77
(m, IH, HI5), 7.18 (m, IH, H16), 8.41 (d, IH,
HI7); FAB HRMS (m/z) C2oH2SN70SS2Lt: Calcd
514.1519, Found 514.1595; MS (FAB) : m/z 514
[M+Li], 508 [M+H], 382 [M+Li+H-sugar], 466
[M+H-C2H20], 403 [M+Li-CsHsNS], 355 [382-
HCN].
N-[2 [[[2-{L-Cysteine] ethylthio] carbonyl] ami-
no]ethyl]-adenosine 10. L-Cysteine hydrochloride
hydrate (78.8 mg, 0.5 mmole) was added to a
solution of9 (0.253 g, 0.5 mmole) in 5 mL CH2Ch,
3.5 mL EtOH and 2.5 mL water. The reaction was
complete in 1 hr at room temperature and was
evaporated to dryness. The residue was
chromatographed on reversed phase silica (30%
H20/MeCN). Final product 10 was obtained as a
white solid (0.220 g, 80%). m.p. 140 DC (d) IR
(Nujol) : ern" 3329; 1969; 1622; 1456 cm'. I3C
NMR (150 MHz, D20) : 91.3 (Cl'), 76.8
(C2'), 73.6 (C3'), 88.7 (C4'), 64.5 (C5'), 155.2 (C2),
150.2 (C4), 157.5 (C5), 122.3 (C6), 142.9 (C8),
42.7 (C9), 41.7 (ClO), 35.5 (CII), 37.6 (CI2), 40.7
(C13), 56.2 (C14), 177.2 (C15), 175.4 (C16); 'H
NMR (600 MHz, D20) : 8 5.94 (d, IH, HI'), 4.69
(m, IH, H2'), 4.36 (m, lH, H3'), 4.24 (m, IH, H4'),
3.87 and 3.78 (dd, 2H, H5'), 8.07 (s, IH, H2), 8.19
(s, IH, H8), 3.62 (m, 2H, H9), 3.45 (t, 2H, HIO),
2.78 (t, 2H, 11H), 2.53 (m, 2H, 12H), 3.18 and 2.97
(m, 2H, H13), 3.96 (t, lH, H14); FAB HRMS
(m/z) CI8H27N707S2Lt: Calcd 524.5329; Found
524.5374.
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